Endo Settles Pay-For-Delay Suit As FTC Renews Watson Case
Endo settled Federal Trade Commission claims Monday that it violated antitrust laws by using pay-for-delay settlements to block consumers' access to generic versions of drugs Opana ER and Lidoderm, while the...To view the full article, register now.
Already a subscriber? Click here to view full article